## 5 Future Challenges and Conclusions
(2020) [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON] Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer. _Metabolites_**2020**, _10_, 67. [CrossRef]
* [PERSON] et al. (2016) [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. _J. Extracellular Vesicles_**2016**, \(5\), 32570. [CrossRef]
* [PERSON] et al. (2020) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells. _J. Ovarian Res._**2020**, _13_, 9. [CrossRef] [PubMed]
* [PERSON] et al. (2017) [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. _Eur. J. Cancer_**2017**, _70_, 122-132. [CrossRef]* (177) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles. _PLoS ONE_**2016**, _11_, e0151339. [CrossRef] [PubMed]
* (178) [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON] Metabolomic Analysis of Small Extracellular Vesicles Derived from Pancreatic Cancer Cells Cultured under Normoxia and Hypoxia. _Metabolites_**2021**, _11_, 215. [CrossRef]
* (179) [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] Analysis and Simulation of Glioblastoma Cell Lines-Derived Extracellular Vesicles Metabolome. _Metabolites_**2020**, _10_, 88. [CrossRef]
* (180) [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON] Metabolomics Applied to the Study of Extracellular Vesicles. _Metabolites_**2019**, \(9\), 276. [CrossRef]
* (181) [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON] Lysophospholipidg et cancer: Etat des lieux et perspectives [Lysophospholipids and cancer: Current status and perspectives]. _Pathol. Biol._**2005**, _53_, 57-62. [CrossRef] [PubMed]
* (182) [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: Application to RCC urinary exosomes. _Electrophoresis_**2012**, _33_, 689-696. [CrossRef]
* (183) [PERSON]; [PERSON] Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications. _Cells_**2019**, \(8\), 89. [CrossRef] [PubMed]
* (184) [PERSON]; [PERSON] Glutamine addiction: A new therapeutic target in cancer. _Trends Biochem. Sci._**2010**, _35_, 427-433. [CrossRef] [PubMed]
* (185) [PERSON]; [PERSON]; [PERSON] Structural biology of the purine biosynthetic pathway. _Cell Mol. Life Sci._**2008**, _65_, 3699-3724. [CrossRef]
* (186) [PERSON] Serine, glycine and one-carbon units: Cancer metabolism in full circle. _Nat. Rev. Cancer_**2013**, _13_, 572-583. [CrossRef]
* (187) [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON] Metabolomics toward personalized medicine. _Mass Spectrom. Rev._**2019**, _38_, 221-238. [CrossRef]
* (188) [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism. _Sci. Rep._**2017**, \(7\), 42798. [CrossRef]
* (189) [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; et al. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression. _J.